(Q33808549)

English

The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver?

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

title

The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29 July 2017

Blume HH

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10620723

retrieved

29 July 2017

Schug BS

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10620723

retrieved

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10620723

retrieved

29 July 2017

published in

European Journal of Pharmaceutical Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10620723

retrieved

29 July 2017

volume

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10620723

retrieved

29 July 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10620723

retrieved

29 July 2017

page(s)

117-121

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10620723

retrieved

29 July 2017

cites work

The effect of mannitol on the oral bioavailability of cimetidine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900076-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900076-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro-in vivo relationships of several "immediate" release tablets containing a low permeability drug.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900076-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0928-0987(99)00076-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10620723

retrieved

29 July 2017

PubMed publication ID

10620723

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10620723

retrieved

29 July 2017

(Q33808549)

The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)